Crown Bioscience Names Global Strategy SVP

Laurie Heilmann has been appointed senior vice president global strategy, marketing business development at Crown Bioscience. Ms. Heilmann has more than 30 years of experience in medical and life science services, and has extensive experience building teams and increasing sales, profits, market share and new market development. She brings experience in medical devices, software, Phase I-IV clinical research and knowledge of FDA and sponsor requirements in the U.S., Europe, India and Asia.
 
Prior to joining the company, Ms. Heilmann held several senior positions at drug and device development companies, including American College of Radiology for profit imaging CRO, Image Metrix, and Ockham Development Group.
 
“We are delighted to welcome Laurie to our team” comments Jean Pierre Wery, president of Crown Bioscience. “We have an ambitious growth strategy for our Translational Service Platforms and Laurie’s hands-on experience with strategic vision in marketing and business development will be instrumental in the effort to drive forward our global operations. Her invaluable perspectives will considerably increase our influence in the global pre-clinical arena, allowing Crown to pursue helping our clients improve clinical outcomes for patients throughout the world.”